How far has China come in developing COVID-19 vaccines? At a time when China is stepping up its vaccine diplomacy, and in a country that has seen a series of major vaccine accidents in recent years, it is legitimate and necessary for outsiders to question how safe and effective the vaccine is.
The number of vaccines is one of the highest in the world but none has completed phase III trials
The remarks by Zheng Zhongwei, head of China’s National health Commission, as reported by the official Xinhua News Agency on June 16, were supposed to be an authoritative statement on the level of COVID-19 vaccine in China, and contained several interesting details.
He said, “There are already five novel Coronavirus vaccine phase III clinical trials in China, which ranks among the highest in the world”. Indeed, according to the data released by WHO earlier, there are 11 vaccines that have entered phase III trials, which undoubtedly ranks among the highest in the world “.
He said China’s next “vaccine development has entered the sprint phase, we are in the world square, but not for the first false start”, China started early, vaccine development input, has entered the final stage, belong to the world’s first phalanx, these are not problems, but then said “don’t jump start for the first” has the problem, this sentence seems to imply that other countries competing for first, China firmly, “this is not the case. Now “robbed the first” Pfizer in the U.S. and Germany biotechnology company Pfizer vaccine research and development, they announced the third phase of the experiment at the end of the data, to the United States it is proposed the most complete information, safety, efficacy and side effects of hazards, there are detailed, Pfizer has been approved, the United States and Britain, estimates that the eu will be approved, on December 21, now waiting for approval of the United States mo DE new vaccines, efficiency is as high as 94.5%, by the American association of independent inspection on Thursday, is expected to pharmaceutical companies approved by the United States will soon, on the other hand, A vaccine jointly developed by Oxford University and Astrazeneca is also expected to be approved for sale early this year.
Why didn’t China mention the vaccines listed in the Middle East and China
In fact, sinopac’s vaccine has been approved by two Middle Eastern countries, The United Arab Emirates and Bahrain. Why didn’t Zheng Zhongwei speak out about this as the result of “getting the first”?
Explaining the progress of the five vaccines in China, Zheng said, “Relevant parties are continuing to promote the phase III clinical trials of vaccines in a scientific and rigorous manner, and doing the review and approval work in strict accordance with laws and regulations and internationally recognized technical standards, so as to ensure that the vaccines are safe and effective, stand the test of all aspects, and stand the test of history.”
It should be said that this explanation is premised on scientific standards everywhere, which should be a footnote to why The Chinese vaccine has not been “first”, that is, the Chinese vaccine is still in the third phase of the experimental stage, still waiting for the final conclusion. However, China’s national medicine vaccine in the Middle East two countries approved marketing is how to go? If you do not complete the third phase of the experiment, rushed to the market, are not afraid of trampled life? Why were these two countries able to approve the listing? Some people pointed out that the data used in the uae and Bahrain approval documents were provided by Sinopac itself, rather than by an independent body. The UAE thought the data was good and approved it?
According to the Washington Post, the United Arab Emirates has started to get China’s COVID-19 vaccine, but those with High blood pressure cannot. This raises the question again. The incidence of hypertension is relatively high, and hypertension patients belong to the high-risk group of COVID-19, so they should be given priority for vaccination. Why should they be excluded? A vaccine developed by Pfizer of the United States and Biotechnology of Germany involved more than 9,000 people with high blood pressure.
Zheng Zhongwei also talked about since the outbreak of the new champions league in China, the effective control of domestic don’t have to carry out the condition of the third phase of clinical trial, that is why the third phase of experiment mainly in overseas, “is faced with some difficulties and challenges,” this sentence may be partially revealed why China hasn’t released the third phase of the vaccine to the experimental results of reason, at least firm sinovac group in the process of the Brazilian test is not smooth, have been suspended, then resume testing, is now health authorities accused the standard is not transparent and so on.
Domestic vaccines are less risky than Pfizer vaccines
Zheng Zhongwei conversation than official media to the Chinese vaccine overly trumpeting appear level and closer to the true, because of the official media too much, too much beyond the point of view, in the Chinese mind caused a feeling of China vaccine in the world, and, on the premise of vaccine is far from complete experimental steps, China in the summer and fall to the inoculation of hundreds of thousands of people, create the false impression that a Chinese vaccine would have come out, but don’t have any scientific data vaccination will be confirmed.
Vaccines must be after the third phase of clinical trial results to determine the efficacy and safety of vaccines in China haven’t through phase iii, but Mr Hu said, “if let you new crown vaccine, there are two options, the price is similar, is a Chinese domestic vaccine, one is the Pfizer vaccine, vaccination which one will you choose?” He then asked himself: “It is not patriotic that Lao Hu would choose to get domestic COVID-19 vaccine anyway. I really think the risk of domestic COVID-19 vaccine will be smaller and more reliable.” The question is, how can a domestic vaccine, which has not yet passed phase III clinical trials, be any less risky or more reliable than Pfizer, which has already passed trials?
Fosun’s purchase of Pfizer’s vaccine raises questions
The recent news that Fuxing Pharmaceutical Group has purchased 100 million doses of vaccine from abroad has also aroused some Chinese Netizens’ doubts. Some people said, “Don’t we have enough vaccines ourselves? Why pay such a high price to import them from abroad? “Don’t say your vaccines are good, but when you use them, you should trust others, just like those who have the means to buy foreign milk powder,” said another netizen.
The Pfizer vaccine was developed in partnership with BioNTech of Germany, but the China News Service report said: “The vaccine developed by Fosun And BioNTech of Germany…” In fact, Fosun pharmaceutical did not participate in the research and development, just a Chinese agent. Relevant fosun group purchasing foreign vaccine and reports are vague, after all, fosun group buy vaccine is the United States and Germany biotechnology r&d of Pfizer vaccine, but the official media deliberately not to mention this is Pfizer vaccine, or just said from the aspects of partner German Renaissance group purchasing vaccines, create the false impression that a revival in research and development.
Due to the cover-up, the Beijing Daily reported in confusion: “Shanghai Fosun Pharmaceutical Co., Ltd. is conducting phase II clinical trials of the mRNA novel coronavirus vaccine BNT162B2 in Jiangsu province. It is expected that by 2021, at least 100 million doses of this vaccine, which is deeply involved in the international cooperation of Fosun Pharma, will be available to the Chinese public to inoculated against the ongoing COVID-19 epidemic “.
Why not just make it clear that the vaccines Fuxing bought were those developed by Pfizer and German biotechnology? Why is Fuxing conducting phase II trials in China after Pfizer’s vaccine has completed phase III trials and been approved for sale in the US and UK? Why is it said that Fuxing group is “deeply involved in international cooperative research and development”, but Pfizer’s vaccine research and development is always conducted between Pfizer and German biotechnology, and no one has heard of Fuxing’s deep involvement?
Some suspect this is paving the way for Fuxing to import Pfizer vaccine branded “Fuxing Vaccines” from Germany.
Recent Comments